Open Access Government1d
First-ever NHS treatment approved for advanced Hodgkin lymphoma
New combination therapy will be available on the NHS, offering new hope to people with advanced Hodgkin lymphoma ...
UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients
NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.
The Pharma Letter1d
NICE recommends Takeda’s brentuximab vedotin for HL
The UK’s health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended brentuximab ...
New blood cancer NHS treatment could help hundreds of people
A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced ...
Hodgkin lymphoma update as new treatment could help 800 people
A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced ...
The Hereford Times2d
New treatment for advanced blood cancer recommended for use on NHS
It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence.
Standard-Journal4d
TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer
Genmab A/S(Nasdaq: GMAB) announced today that the European Commission (EC) has granted marketing authorization for TIVDAK ® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy ...